Testosterone 100mg pellet, 1 count (NDC 69761-110-01), 6 count (NDC 69761-110-06), 12 count (NDC ...
FDA Drug Recall #D-0231-2019 — Class II — October 17, 2018
Recall Summary
| Recall Number | D-0231-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 17, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Qualgen, LLC |
| Location | Edmond, OK |
| Product Type | Drugs |
Product Description
Testosterone 100mg pellet, 1 count (NDC 69761-110-01), 6 count (NDC 69761-110-06), 12 count (NDC 69761-110-12), and 30 count (NDC 69761-110-30) vials, Rx Only Qualgen, LLC, Edmond, OK 73013
Reason for Recall
Lack of Assurance of Sterility
Distribution Pattern
Nationwide.
Lot / Code Information
Lots: C232 BUD: 11/3/2018; C239 BUD: 11/14/2018; C246 BUD: 11/29/2018; C260 BUD: 12/19/2018; D004 BUD: 1/4/2019; D017 BUD: 1/18/2019; D023 BUD: 1/26/2019; D053 BUD: 3/6/2019
Other Recalls from Qualgen, LLC
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0517-2025 | Class III | Testosterone 200 mg Pellet packaged in 1mL ambe... | Jun 16, 2025 |
| D-0234-2019 | Class II | Testosterone 25 mg pellet, 1 count (NDC: 69761-... | Oct 17, 2018 |
| D-0236-2019 | Class II | Testosterone 50mg pellet, 1 count (NDC 69761-15... | Oct 17, 2018 |
| D-0227-2019 | Class II | Estradiol 15mg pellet, 1 count (NDC 69761-015-0... | Oct 17, 2018 |
| D-0226-2019 | Class II | Estradiol 12.5mg pellet, 1 count (NDC 69761-012... | Oct 17, 2018 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.